Circady Wins 2019 MedTech Breakthrough Award for “Best Sleep Monitoring Solution”

Circady, an innovative insomnia treatment created from our digital health research program SleepWell, won a 2019 MedTech Breakthrough Award for "Best Sleep Monitoring Solution."

Insomnia is a common symptom of PTSD that can have debilitating effects.

Approximately 70-91% of PTSD patients have difficulty falling or staying asleep.

Circady, an innovative insomnia treatment created from our digital health research program SleepWell, won a 2019 MedTech Breakthrough Award for “Best Sleep Monitoring Solution.”

Insomnia is a common symptom of PTSD and TBI that can have a debilitating impact on patients, and early intervention is critical to preempt disease progression associated with physical or emotional trauma,” said Magali Haas, MD, PhD, CEO and President, Cohen Veterans Bioscience. We think it is critical to support this technology in tracking sleep, which enables healthcare providers to define individual health trajectories and customize treatment to improve the everyday lives of those suffering from sleep disorders.”

Read the press release on PRWeb and learn more.

Share this article:

More from CVB

https://www.cohenveteransbioscience.org/wp-content/themes/cvb-theme/assets/img/icon-news-card.png

A Message from CEO Peter Hoehn

https://www.cohenveteransbioscience.org/wp-content/themes/cvb-theme/assets/img/icon-news-card.png

CVB President Nicole Harmon, PhD Discusses How Traumatic Brain Injury Has Impacted Her Family

https://www.cohenveteransbioscience.org/wp-content/uploads/2024/01/bibi-C-3.jpg

Interview with Bibi Carmouche, BASE Jumper for 22 Jumps Camelback Mountain 2024

https://www.cohenveteransbioscience.org/wp-content/uploads/2023/03/cohen-veterans-bioscience-22-jumps.jpg

Cohen Veterans Bioscience and 22 Jumps Announce Parachuting with Purpose: Recognizing the Crisis of Veterans Suicide as a Result of Traumatic Brain Injury (TBI) and PTSD

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.

For Media Inquiries

Please feel free to email us at media@cohenbio.org